Meige Syndrome with Apraxia of Lid Opening after the Discontinuation of Sulpiride Treatment

S. Tsuji; S. Kikkawa; J. Horiguchi; H. Yamashita; A. Kagaya; S. Morinobu; S. Yamawaki

doi:10.1055/s-2002-33198

Pharmacopsychiatry, Table of Contents

Pharmacopsychiatry 2002; 35(4): 155-156
DOI: 10.1055/s-2002-33198

Case Report

Meige Syndrome with Apraxia of Lid Opening after the Discontinuation of Sulpiride Treatment

S. Tsuji¹ , S. Kikkawa¹ , J. Horiguchi² , H. Yamashita¹ , A. Kagaya¹ , S. Morinobu¹ , S. Yamawaki¹

¹Department of Psychiatry and Neurosciences, Hiroshima University School of Medicine, Hiroshima, Japan
²Department of Psychiatry. Shimane Medical University, Shimane, Japan

Abstract

We report a case of Meige syndrome with apraxia of lid opening that lasted for about seven months after discontinuation of sulpiride treatment. To our knowledge, this is the first report demonstrating that Meige syndrome with apraxia of lid opening is induced by sulpiride, and that the condition persists.

Full Text

References

1 Ananth J, Edelmuth E, Dargan B. Meige’s syndrome associated with neuroleptic treatment. Am J Psychiatry. 1988; 145 513-515
2 Boghen D. Apraxia of lid opening: a review. Neurology. 1997; 48 1491-1494
3 Casey D E. Pharmacology of blepharospasm-oromandibular dystonia syndrome. Neurology. 1980; 30 690-695
4 Farde L, Nordstrom A L. PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients. Br J Psychiatry Suppl. 1992; 17 30-33
5 Hayashi T, Furutani M, Taniyama J, Kiyasu M, Hikasa S, Horiguchi J J. et al . et alNeuroleptic-induced Meige’s syndrome following akathisia: pharmacologic characteristics. Psychiatry Clin Neurosci. 1998; 52 445-448
6 Kebabian J W, Calne D B. Multiple receptors for dopamine. Nature. 1979; 277 93-96
7 Meige H. Les convulsions de la face, une forme clinique de convulsion faciale, bilaterale et médiane. Revue Neurologique. 1910; 20 437-443
8 Miller L G, Jankovic J. Sulpiride-induced tardive dystonia. Mov Disord. 1990; 5 83-84
9 Moore S, Kenyon P. Atypical antipsychotics, clozapine and sulpiride do not antagonise amphetamine-induced stereotyped locomotion. Psychopharmacology (Bed). 1994; 114 123-130
10 Seeman P, Corbett R, Van Tol H H. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. Neuropsychopharmacology. 1997; 16 93-110; discussion 1 - 35
11 Stahl S M. Conventional Neuroleptic Drugs for Schizophrenia and Novel Antipsychotic Agents. Essential Psychopharmacology. United Kingdom; CAMBRIDGE UNIVERSITY PRESS 1996: p.270
12 Stahl S M, Yesavage J A, Berger P A. Pharmacologic characteristics of Meige dystonia: differentiation from tardive dyskinesia. J Clin Psychiatry. 1982; 43 445-446
13 Tamminga C A, Gerlach J. New neuroleptics and experimental antipsychotics in schizophrenia. in Psychopharmacology, The third generation of progress. ed. by Meltzer HY New York; Raven Press 1987: p. 1129-1140
14 Tanner C M, Glantz R H, Klawans H L. Meige disease: acute and chronic cholinergic effects. Neurology. 1982; 32 783-785
15 Tolosa E S, Lai C. Meige disease: striatal dopaminergic preponderance. Neurology. 1979; 29 1126-1130
16 Weiner W J, Nausieda P A, Glantz R H. Meige syndrome (blepharospasm-oromandibular dystonia) after long-term neuroleptic therapy. Neurology. 1981; 31 1555-1556

Shigeto Yamawaki,MD, PhD

Department of Psychiatry and Neurosciences

Hiroshima University School of Medicine

1-2-3 Kasumi, Minami-ku

Hiroshima 734-8551

Japan

Phone: +81 (82) 257-5207

Fax: +81 (82) 257-5209